MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $1.55 | Prev. Close $1.55 | Circuit Range N/A |
Day Range $1.55 - $1.60 | Year Range $1.27 - $5.20 | Volume 11,745 |
Average Traded $1.59 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
24-Dec-25 | $1.55 | $1.59 | +0.00% |
24-Dec-25 | $1.55 | $1.59 | +2.57% |
23-Dec-25 | $1.59 | $1.55 | -4.89% |
22-Dec-25 | $1.52 | $1.64 | +8.64% |
19-Dec-25 | $1.51 | $1.50 | -1.31% |
18-Dec-25 | $1.51 | $1.52 | +2.01% |
17-Dec-25 | $1.48 | $1.50 | +1.01% |